10th International Symposium on Ocular Pharmacology and Therapeutics, Paris, France
7 March 2013 - 7 March 2013
France
The 10th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT 2013) will take place from 7 to 10 March 2013 in Paris, France.
The prevalence of blindness in Europe is estimated to be about 0.3 per cent, which represents seven per cent of total world blindness. Most sight-threatening eye diseases among Europeans are age related, and the number of people affected will increase as a result of population ageing and the continued rise in life expectancy.
Advancement in the treatment of blindness depends on the development of new technologies that enable early detection, follow-up, and treatment of disease. New treatments in ophthalmology are rapidly evolving, with the recent breakthrough of new medicines for wet age-related macular degeneration. Research is also ongoing in new eye diseases where no treatment is yet available, such as retinitis pigmentosa and dry age-related macular degeneration.
The conference will discuss methods for measuring visual function in clinical trials, developing stem cells and gene therapy for retinal diseases, treatment for macular diseases and inflammation in the eye, repairing the corneal surface with stem cells and treatment for dry eyes. It will enable interactions between European regulators, doctors and patient representatives and pharmaceutical industry in this area.For further information, please visit:
http://isopt.net/index.php(opens in new window)
The prevalence of blindness in Europe is estimated to be about 0.3 per cent, which represents seven per cent of total world blindness. Most sight-threatening eye diseases among Europeans are age related, and the number of people affected will increase as a result of population ageing and the continued rise in life expectancy.
Advancement in the treatment of blindness depends on the development of new technologies that enable early detection, follow-up, and treatment of disease. New treatments in ophthalmology are rapidly evolving, with the recent breakthrough of new medicines for wet age-related macular degeneration. Research is also ongoing in new eye diseases where no treatment is yet available, such as retinitis pigmentosa and dry age-related macular degeneration.
The conference will discuss methods for measuring visual function in clinical trials, developing stem cells and gene therapy for retinal diseases, treatment for macular diseases and inflammation in the eye, repairing the corneal surface with stem cells and treatment for dry eyes. It will enable interactions between European regulators, doctors and patient representatives and pharmaceutical industry in this area.For further information, please visit:
http://isopt.net/index.php(opens in new window)